144 related articles for article (PubMed ID: 8394297)
1. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Baselga J; Kris MG; Scher HI; Phillips M; Heelan RT
Invest New Drugs; 1993 Feb; 11(1):85-6. PubMed ID: 8394297
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Chang AY; Tu ZN; Smith JL; Bonomi P; Smith TJ; Wiernik PH; Blum R
Invest New Drugs; 1995; 13(2):137-41. PubMed ID: 8617576
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
Warrell RP; Coonley CJ; Straus DJ; Young CW
Cancer; 1983 Jun; 51(11):1982-7. PubMed ID: 6839291
[TBL] [Abstract][Full Text] [Related]
4. Gallium nitrate: the second metal with clinical activity.
Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
Cancer Treat Rep; 1986 Nov; 70(11):1311-9. PubMed ID: 3533251
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Adelson MD
Am J Clin Oncol; 1991 Aug; 14(4):349-51. PubMed ID: 1862766
[TBL] [Abstract][Full Text] [Related]
6. Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.
Crawford ED; Saiers JH; Baker LH; Costanzi JH; Bukowski RM
Urology; 1991 Oct; 38(4):355-7. PubMed ID: 1755146
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.
Seidman AD; Scher HI; Heinemann MH; Bajorin DF; Sternberg CN; Dershaw DD; Silverberg M; Bosl GJ
Cancer; 1991 Dec; 68(12):2561-5. PubMed ID: 1933802
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.
Keller J; Bartolucci A; Carpenter JT; Feagler J
Cancer Treat Rep; 1986 Oct; 70(10):1221-3. PubMed ID: 3530448
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD; Hanjani P
Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer.
Webster LK; Olver IN; Stokes KH; Sephton RG; Hillcoat BL; Bishop JF
Cancer Chemother Pharmacol; 2000; 45(1):55-8. PubMed ID: 10647502
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer. A Southwest Oncology Group study.
Williamson SK; Crowley J; Livingston RB; Weiss G
Invest New Drugs; 1993 Feb; 11(1):81-3. PubMed ID: 8394296
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
Seligman PA; Crawford ED
J Natl Cancer Inst; 1991 Nov; 83(21):1582-4. PubMed ID: 1960756
[No Abstract] [Full Text] [Related]
13. Phase I-II clinical trial of gallium nitrate (NSC-15200).
Samson MK; Fraile RJ; Baker LH; O'Bryan R
Cancer Clin Trials; 1980; 3(2):131-6. PubMed ID: 7428136
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD
Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
Chitambar CR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):39-44. PubMed ID: 15651176
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
Evans WK; Eisenhauer EA; Cormier Y; Ayoub J; Wierzbicki R; Laberge F; Shepherd FA
J Clin Oncol; 1990 Mar; 8(3):390-5. PubMed ID: 2155309
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer.
Senderowicz AM; Reid R; Headlee D; Abornathy T; Horti J; Lush RM; Reed E; Figg WD; Sausville EA
Urol Int; 1999; 63(2):120-5. PubMed ID: 10592501
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer.
Herben VM; ten Bokkel Huinink WW; Schot ME; Hudson I; Beijnen JH
Anticancer Drugs; 1998 Jun; 9(5):411-8. PubMed ID: 9660538
[TBL] [Abstract][Full Text] [Related]
19. Gallium nitrate in the treatment of bladder cancer.
Einhorn L
Semin Oncol; 2003 Apr; 30(2 Suppl 5):34-41. PubMed ID: 12776258
[TBL] [Abstract][Full Text] [Related]
20. Treatment with gallium nitrate: evidence for interference with iron metabolism in vivo.
Seligman PA; Moran PL; Schleicher RB; Crawford ED
Am J Hematol; 1992 Dec; 41(4):232-40. PubMed ID: 1337663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
